AVTX earnings
Avalo Therapeutics (AVTX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
AVTX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 5, 2026 | -0.34 | -0.59 | 42.21% | – |
| Q2 2026 | Aug 6, 2026 | -0.83 | -0.58 | -42.43% | – |
| Q1 2026 | May 13, 2026 | -0.98 | -1.00 | 2.00% | – |
| Q4 2025 | Mar 23, 2026 | -0.74 | -1.54 | 51.95% | $59.00K |
| Q3 2025 | Nov 6, 2025 | -2.19 | -1.67 | -31.14% | $0.00 |
| Q2 2025 | Aug 7, 2025 | -1.92 | -1.43 | -34.27% | – |
| Q1 2025 | May 12, 2025 | -1.25 | -1.07 | -16.82% | – |
| Q3 2024 | Nov 7, 2024 | -2.83 | -1.19 | -137.82% | $249.00K |
| Q2 2024 | Aug 12, 2024 | -14.07 | -6.70 | -110.00% | $0.00 |
| Q1 2024 | May 13, 2024 | -5.98 | -1.18 | -406.78% | $0.00 |
| Q3 2023 | Nov 9, 2023 | -26.19 | -261.90 | 90.00% | $236.00K |
| Q2 2023 | Aug 3, 2023 | -140.48 | -214.29 | 34.44% | $643.00K |
| Q1 2023 | May 4, 2023 | -202.38 | – | – | $475.00K |
| Q4 2022 | Mar 29, 2023 | -247.62 | – | – | $896.00K |
| Q3 2022 | Nov 7, 2022 | 80.95 | – | – | $14.95M |
- AVTX beat EPS estimates in 5 of its last 12 reports.
Updated 2026-11-09 19:47 UTC